Considering the obtained correlations and the fact that the increased levels of β2M indicate the patients with the aggressive lymphomas who will experience relapse [13], we analyzed correlation between cystatin C and β2M in patients with partial or complete remission after three cycles of chemotherapy (Table 2). This evidence concerns the gene CST3 and lymphoma.